Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
3004 articles
Articles
LataMed AI Corp. Forward Stock Split Takes Effect, Signaling Corporate Restructuring
LataMed AI Corp. announced the effectiveness of its 5-for-1 forward stock split, a corporate action aimed at streamlining its capital structure as it advances its AI-driven telemedicine platforms in emerging markets.
July 15, 2026Read the full article
Study Links Higher Death Rates in Adults With Congenital Heart Disease to Low Income and Limited Insurance
A new study reveals that adults with congenital heart disease living in U.S. states with lower household incomes and fewer insured residents face higher mortality and disability, highlighting the critical role of specialized cardiac care access.
July 15, 2026Read the full article
New Book Bridges Technology Gap for Families of People With Serious Mental Illness
Nicole Drapeau Gillen's 'Connected Care: A Practical Guide to Technology for Serious Mental Illness' provides families and caregivers with a comprehensive, plain-language guide to digital tools, financial assistance, and AI applications that can improve care for serious mental illness.
July 15, 2026Read the full article
CollectionPro Surpasses 1,000 IDR Case Filings, Strengthening Its Leadership in Out-of-Network Claims Recovery
CollectionPro has filed over 1,000 Independent Dispute Resolution cases under the No Surprises Act, highlighting the growing need for specialized out-of-network reimbursement services as regulations become more complex.
July 15, 2026Read the full article
Springs Rejuvenation Brings Stem Cell Exosome and Micro FUE Treatments to Austin, TX
Springs Rejuvenation expands to Austin, offering non-surgical regenerative treatments like the Stem 3 Protocol, stem cell exosome therapy, micro FUE hair restoration, and joint pain relief, providing local access to advanced care previously requiring travel.
July 14, 2026Read the full article
SS Innovations CEO Details Strategy to Expand Affordable Robotic Surgery Globally
Dr. Sudhir Srivastava outlines SSII's plan to broaden access to robotic surgery through lower-cost technology, training, and telesurgery, with over 200 systems installed and 11,700 procedures completed.
July 14, 2026Read the full article
Quantum BioPharma Advances LUCID-MS Therapy for Multiple Sclerosis into Phase 2 Trials
Quantum BioPharma's LUCID-MS, a neuroprotective therapy targeting myelin repair in multiple sclerosis, showed positive Phase 1 safety data and is moving to Phase 2 trials, potentially offering a first-in-class treatment approach.
July 14, 2026Read the full article
Earth Science Tech Inc. Reports Transformational Fiscal Year as Healthcare Subsidiaries Achieve Positive Cash Flow
Earth Science Tech Inc. (ETST) announced a strong fiscal 2026 with several healthcare subsidiaries turning cash-flow positive, highlighting a debt-free growth strategy and share repurchases to enhance shareholder value.
July 14, 2026Read the full article
NuggMD Donates to NORML After Historic Federal Cannabis Rescheduling
Following the federal government's historic rescheduling of cannabis to Schedule III, NuggMD pledges 3% of weekly revenue to NORML, marking a significant shift in federal cannabis policy and the need for continued advocacy.
July 14, 2026Read the full article
HeartBeam Patent Expands Cardiac Monitoring Platform to Include Heart Failure and Structural Heart Disease Capabilities
HeartBeam has received a new U.S. patent that integrates acoustic sensing and thoracic impedance measurement into its credit card-sized ECG device, enabling future applications in heart failure and structural heart disease monitoring.
July 14, 2026Read the full article
Wolfson Group Broadens U.S. Retail Strategy to Include Brick-and-Mortar and Additional Online Channels
Wolfson Group, a Scotland-based wellness company, announces expansion of its U.S. retail presence beyond Amazon to include more online retailers and physical stores, aiming to increase accessibility for its science-led wellness brands.
July 14, 2026Read the full article
AgeReverse Announces U.S. Expansion with Comprehensive Longevity Supplement RESURGE
Canadian longevity brand AgeReverse plans to enter the U.S. market with its flagship formulation RESURGE, targeting all 12 Hallmarks of Aging through a multi-ingredient approach rather than single-nutrient solutions.
July 14, 2026Read the full article
Uterine Fibroids Disproportionately Affect Women of Color; Uterine Fibroid Embolization Offers Non-Surgical Relief
Uterine fibroids affect up to 80% of Black women by age 50, yet many are unaware of non-surgical treatment options like uterine fibroid embolization (UFE), which can significantly improve quality of life.
July 14, 2026Read the full article
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides received ethics committee approval in the Democratic Republic of the Congo to conduct a Phase II trial of its oral NV-387 gummies for the Bundibugyo ebolavirus outbreak, offering a potential advantage over infusion therapies in resource-limited settings.
July 13, 2026Read the full article
SS Innovations International CEO Outlines Strategy to Expand Affordable Robotic Surgery
SS Innovations International Inc. (NASDAQ: SSII) is focusing on affordability and accessibility to expand robotic surgery globally, leveraging AI, automation, and telesurgery to differentiate its SSi Mantra system.
July 13, 2026Read the full article
Thyroid Hormone Shows Promise in Preventing Pediatric Brain Tumor Recurrence
Researchers found that triiodothyronine (T3), a commonly prescribed thyroid hormone, may enhance standard chemotherapy to prevent recurrence of pediatric brain tumors, based on laboratory and animal studies.
July 13, 2026Read the full article
From Brooklyn to the Biggest Names in Sports and Entertainment: Mitch Gould's Quintessential America
The article profiles Mitch Gould, a third-generation retail distribution professional who created the Evolution of Distribution® model, built Amazon's sports nutrition category from scratch, and has collaborated with numerous sports and entertainment legends.
July 13, 2026Read the full article
LataMed AI Evaluates Global Healthcare Expansion at World Health Expo 2027
LataMed AI Corp. plans to attend World Health Expo 2027 in Dubai to explore international expansion opportunities for its digital healthcare ecosystem beyond Latin America.
July 13, 2026Read the full article
When a Child Changes Overnight: Why Some Sudden Behavioral Changes May Be Telling a Bigger Medical Story
Dr. Roseann Capanna-Hodge challenges clinicians to consider biological underpinnings like neuroimmune disorders, nervous system dysregulation, and inflammation when children experience sudden behavioral changes, emphasizing that proper healing requires understanding the body's interconnected systems.
July 13, 2026Read the full article
Gum Disease Bacteria May Contribute to Hardening of Heart Valves, Study Suggests
A lab study presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2026 found that the bacteria Porphyromonas gingivalis, which causes gum disease, may promote calcium buildup and inflammation in the aortic valve, potentially leading to calcific aortic valve stenosis.
July 12, 2026Read the full article
Novel Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence and Enhances Safety in Preclinical Study
Researchers developed a feeder-free TIL expansion protocol that minimizes IL-2 use, reduces T-cell exhaustion, and combined with low-dose PD-1 blockade improves anti-tumor efficacy and tolerability in preclinical models, potentially broadening TIL therapy access.
July 12, 2026Read the full article